Form 4: Novavax Director Rachel K. King Exercises Restricted Stock Units, Increases Direct Shareholding

Novavax Director Rachel K. King reported the exercise of 10,420 Restricted Stock Units and the acquisition of an equal number of common shares, increasing her direct beneficial ownership to 25,190 shares.

Summary

• Rachel K. King, a Director of Novavax Inc. (NVAX), executed a transaction on June 12, 2025.
• She exercised 10,420 Restricted Stock Units (RSUs), which were derivative securities.
• As a result of the RSU exercise, she acquired 10,420 shares of Novavax Common Stock at an acquisition price of $0 per share.
• Following this transaction, her direct beneficial ownership of Novavax Common Stock increased to 25,190 shares.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine insider equity award exercise, which is generally seen as a positive sign of insider ownership alignment, but it does not convey new financial performance or strategic news.

Positives

• The exercise of Restricted Stock Units by a director converts equity awards into direct share ownership, which can align insider interests more closely with those of public shareholders.

Future Outlook

This SEC Form 4 filing reports a specific insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This document is a routine insider transaction report (Form 4) and does not provide broader industry context or trends. It solely details a change in beneficial ownership for a director of Novavax Inc.

Stakeholder Impact

• Shareholders: The increase in direct share ownership by a director may be viewed positively as it enhances alignment between management and shareholder interests.

Key Dates

Keywords

Novavax, NVAX, SEC Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, Equity Compensation, Director, Rachel K. King